ORP-6 Activators
ORP-6 Activators are a diverse set of chemical compounds that, through various signaling mechanisms, enhance the functional activity of ORP-6. These activators operate through distinct pathways that converge on the lipid signaling processes ORP-6 is implicated in. PMA, for instance, by mimicking diacylglycerol, directly activates PKC, which in turn can phosphorylate and activate ORP-6. Similarly, Forskolin and Isoproterenol, via increased cAMP levels, activate PKA, leading to potential phosphorylation events that enhance ORP-6 activity. Sphingosine-1-phosphate and Lysophosphatidic acid (LPA) work through receptor-mediated pathways that indirectly influence the lipid environment in which ORP-6 functions. These activators, along with Cyclic ADP-ribose through calcium signaling modulation, and Arachidonic Acid through its metabolites, create an optimal lipid signaling milieu for ORP-6 activation.
In addition to these, Nicotinic acid, by contributing to NAD+ biosynthesis, may affect ADP-ribosylation reactions, which could influence ORP-6's activity in lipid signaling pathways. Oleoylethanolamide (OEA) activates PPAR-alpha, potentially affecting lipid metabolism in a manner that supports ORP-6 activation. Ceramide, through its role in sphingolipid metabolism, could have a similar effect. Diacylglycerol (DAG) serves as a direct activator of PKC, which is known to phosphorylate ORP-6, and Inositol 1,4,5-trisphosphate (IP3) mediates therelease of calcium from intracellular stores, possibly affecting ORP-6 through calcium-dependent lipid signaling. Each of these chemicals, by acting on specific biochemical pathways, creates a favorable context for the activation of ORP-6, enhancing its role in maintaining cellular lipid homeostasis without the need for increased transcription or direct activation of the protein itself.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA acts as a diacylglycerol analog to activate protein kinase C (PKC), which can phosphorylate ORP-6 leading to its enhanced activation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin elevates cAMP, which activates PKA. PKA phosphorylation can lead to the activation of ORP-6 through downstream lipid signaling effects. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a beta-adrenergic agonist, increases cAMP and activates PKA, potentially resulting in the phosphorylation and activation of ORP-6. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
This lipid signaling molecule can activate sphingosine-1-phosphate receptors, which may trigger a cascade that activates ORP-6. | ||||||
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $92.00 $240.00 $4328.00 | 9 | |
As a precursor to eicosanoids, it can modulate lipid signaling pathways that ORP-6 is part of, leading to its activation. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
LPA activates G-protein coupled receptors, which might influence ORP-6 activation through alterations in the lipid signaling pathways. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
As a precursor to NAD+, it can affect ADP-ribosylation reactions, which might modify ORP-6 activity. | ||||||
Oleylethanolamide | 111-58-0 | sc-201400 sc-201400A | 10 mg 50 mg | $90.00 $194.00 | 1 | |
OEA can activate PPAR-alpha, potentially influencing lipid metabolism and signaling pathways that include ORP-6. | ||||||
C2 Ceramide | 3102-57-6 | sc-201375 sc-201375A | 5 mg 25 mg | $124.00 $460.00 | 12 | |
Ceramide can initiate a signaling cascade affecting sphingolipid metabolism, which could alter ORP-6 activity. | ||||||